The elevation of miR-351-5p in hippocampal tissues of AD mice can exacerbate mitochondrial fission and mitophagy by targeting mitochondrial Rho GTPase 2 (Miro2), which may be a potential therapeutic target for AD [83]. Here, RHOT2 is linked to Alzheimer disease.